Disclaimer: This information is intended for healthcare professionals and is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical decisions must always be based on the individual patient's condition, available evidence, and the clinician's judgment. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to patient care.

Neonatal Sepsis Shock

Overview

• Definition: Neonatal sepsis is a clinical syndrome of systemic bacterial (or fungal) infection in an infant during the first 28 days of life. Neonatal septic shock is a life-threatening condition characterized by circulatory, cellular, and metabolic abnormalities that lead to inadequate tissue perfusion and oxygen delivery, refractory to fluid resuscitation, and requiring vasopressor and/or inotropic support.
• Epidemiology:
  • Incidence: Varies significantly by gestational age and region. Overall incidence of neonatal sepsis is estimated at 1-5 per 1,000 live births in developed countries, but can be much higher (up to 49 per 1,000 live births) in developing countries, especially for premature infants.
  • Mortality: Septic shock is a leading cause of mortality in neonates, with rates ranging from 10% to 50%, higher in preterm infants and those with multi-organ dysfunction.
  • Prevalence: Accounts for a significant proportion of neonatal intensive care unit (NICU) admissions.
• Classification:
  • Early-Onset Sepsis (EOS): Occurs within the first 72 hours (some define as 7 days) of life. Typically acquired vertically from the mother (e.g., GBS, E. coli).
  • Late-Onset Sepsis (LOS): Occurs after 72 hours (or 7 days) of life. Often nosocomial, related to invasive procedures, indwelling catheters, or community-acquired.
  • Stages of Shock:
    • Compensated Shock: Adequate tissue perfusion maintained by compensatory mechanisms (tachycardia, increased systemic vascular resistance).
    • Decompensated Shock: Compensatory mechanisms fail, leading to hypotension, poor perfusion, and organ dysfunction. Requires aggressive intervention.
    • Refractory Shock: Shock that persists despite adequate fluid resuscitation and vasopressor/inotropic support.

Pathophysiology

• Mechanism: Neonatal septic shock is a complex interplay of host inflammatory responses and pathogen virulence.
  1. Infection: Pathogens (bacteria, fungi) release toxins (e.g., endotoxin from Gram-negative bacteria, exotoxins from Gram-positive bacteria).
  2. Inflammatory Cascade: These toxins activate innate immune cells (macrophages, neutrophils), leading to the release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8).
  3. Systemic Inflammatory Response Syndrome (SIRS): Widespread inflammation causes endothelial dysfunction, increased vascular permeability (leading to fluid leakage into extravascular space, reducing effective circulating volume), vasodilation, and myocardial dysfunction.
  4. Hemodynamic Changes:
     • Distributive Shock: Predominant in neonatal sepsis, characterized by severe vasodilation, resulting in low systemic vascular resistance and maldistribution of blood flow.
     • Cardiogenic Component: Myocardial depression (reduced contractility) due to circulating inflammatory mediators and direct myocardial injury can contribute.
     • Hypovolemic Component: Capillary leak and inadequate fluid intake contribute to reduced intravascular volume.
  5. Microcirculatory Dysfunction: Impaired oxygen extraction and utilization at the cellular level due to microthrombi formation, capillary plugging, and mitochondrial dysfunction, leading to tissue hypoxia.
  6. Metabolic Derangements: Increased anaerobic metabolism leads to lactic acidosis. Impaired glucose metabolism can cause hypo- or hyperglycemia.
  7. Organ Dysfunction: Persistent hypoperfusion and cellular hypoxia lead to multi-organ dysfunction syndrome (MODS), affecting kidneys (acute kidney injury), lungs (ARDS), liver, brain (encephalopathy, seizures), and coagulation system (DIC).
• Risk Factors:
  • Maternal Factors: Chorioamnionitis, prolonged rupture of membranes (>18 hours), maternal fever during labor (>38.0°C), Group B Streptococcus (GBS) colonization without adequate intrapartum prophylaxis, recurrent urinary tract infections, substance abuse.
  • Neonatal Factors:
    • Prematurity (<37 weeks gestation), very low birth weight (<1500g).
    • Low Apgar scores.
    • Male gender.
    • Congenital anomalies (e.g., neural tube defects, heart defects).
    • Genetic syndromes (e.g., Down syndrome).
    • Immunodeficiencies (primary or secondary).
  • Iatrogenic/Environmental Factors (LOS):
    • Invasive procedures: Endotracheal intubation, central venous catheters (umbilical, PICC lines), urinary catheters, mechanical ventilation.
    • Total parenteral nutrition (TPN).
    • Prolonged hospitalization, NICU stay.
    • Lack of adherence to infection control practices (e.g., hand hygiene).
    • Use of broad-spectrum antibiotics, leading to fungal overgrowth or resistant organisms.
• Protective Factors:
  • Maternal Antibodies: Transplacental transfer of IgG provides passive immunity, especially for common pathogens like GBS.
  • Breastfeeding: Provides immunoglobulins (sIgA), lactoferrin, and immune cells that protect the infant's gut and systemic immune system.
  • Intact Skin Barrier: Prevents pathogen entry, especially important for preterm infants who have an immature barrier.
  • Normal Gut Microbiome: Prevents colonization by pathogenic bacteria.
  • Early Removal of Invasive Devices: Reduces risk of nosocomial infections.

Clinical Presentation

Signs and Symptoms

Neonatal sepsis, especially septic shock, can present with subtle and non-specific signs, making early diagnosis challenging. - Cardinal Features: * Temperature Instability: Hypothermia (<36.5°C) is more common than fever (>38.0°C) in neonates with sepsis/shock, particularly in preterm infants. * Respiratory Distress: Tachypnea (>60 breaths/min), grunting, flaring, retractions, apnea, cyanosis. * Cardiovascular Signs: Tachycardia (>160-180 bpm), bradycardia (<100 bpm), prolonged capillary refill time (CRT >3 seconds), weak or bounding pulses, mottling, pallor, hypotension (a late and ominous sign). * Neurological Signs: Lethargy, irritability, poor tone, high-pitched cry, seizures, bulging fontanelle (if meningitis). * Gastrointestinal Signs: Poor feeding, vomiting, abdominal distension, diarrhea, residual feeds, absent bowel sounds. - Early Signs: * Subtle changes in behavior or activity (e.g., "not looking right"). * Feeding intolerance (decreased suck, reduced intake, increased residuals). * Mild temperature instability. * Increased episodes of apnea or desaturations. * Slight increase in respiratory rate. - Advanced Signs: * Hypotension: Mean arterial pressure (MAP) persistently below gestational age-specific thresholds (e.g., MAP < gestational age in weeks for term infants in mmHg). * Poor Perfusion: Cold extremities, mottling, prolonged CRT (>4 seconds), weak or absent peripheral pulses. * Oliguria: Urine output <0.5 mL/kg/hour. * Metabolic Acidosis: Persistent pH <7.20-7.25, high lactate (>2-4 mmol/L). * Disseminated Intravascular Coagulation (DIC): Bleeding from puncture sites, petechiae, purpura. * Multi-organ Failure: Severe respiratory failure requiring high ventilatory support, anuria, jaundice, hypoglycemia/hyperglycemia. - Atypical Presentations: * Isolated hypoglycemia or hyperglycemia without other overt signs of infection. * Unexplained jaundice or worsening jaundice. * Only irritability or excessive sleepiness. * Seizures as the sole presenting symptom, especially in the absence of obvious neurological injury. * Sudden collapse without preceding signs.

Physical Examination

• Inspection:
  • General Appearance: Alertness, activity level, facial expression, body posture, signs of distress.
  • Skin: Color (pallor, cyanosis, mottling, jaundice), presence of petechiae, purpura, rash, turgor, edema.
  • Respiratory: Respiratory rate, presence of grunting, flaring, retractions, nasal flaring, chest wall movement.
  • Cardiovascular: Visible pulsations, apex beat.
  • Abdomen: Distension, bowel loops, visible peristalsis.
• Palpation:
  • Temperature: Palpate extremities for warmth/coolness, comparing to core temperature.
  • Pulses: Palpate all peripheral pulses (femoral, brachial, radial, dorsalis pedis) for quality (strong, weak, bounding) and symmetry.
  • Capillary Refill Time (CRT): Apply pressure to the skin (forehead, sternum, knee) for 5 seconds until blanched, then release. Normal CRT is <3 seconds. Prolonged CRT is a critical sign of poor perfusion.
  • Abdomen: Tenderness, masses, organomegaly (hepatosplenomegaly).
  • Fontanelle: Assess for fullness/tension (bulging fontanelle can indicate meningitis/hydrocephalus).
• Special Tests:
  • Neurological Assessment: Assess tone, reflexes (Moro, suck, grasp), level of consciousness.
  • Cardiovascular Auscultation: Heart rate, rhythm, presence of murmurs (may indicate myocardial dysfunction or persistent patent ductus arteriosus).
  • Respiratory Auscultation: Adventitious sounds (rales, rhonchi, wheezes).

Diagnostic Approach

History Taking

• Key Questions:
  • Maternal History:
    • Group B Streptococcus (GBS) screening status and intrapartum prophylaxis (type, dose, timing).
    • History of maternal fever (temperature and duration) or signs of infection (e.g., foul-smelling amniotic fluid) during labor.
    • Duration of rupture of membranes (PROM >18-24 hours).
    • Maternal chorioamnionitis (clinical diagnosis, histopathology).
    • History of maternal urinary tract infection, sexually transmitted infections.
    • Maternal drug use, medical conditions (e.g., diabetes, hypertension).
  • Birth History:
    • Gestational age, birth weight.
    • Mode of delivery.
    • Apgar scores.
    • Need for resuscitation at birth, meconium-stained fluid.
  • Postnatal History:
    • Onset of symptoms: When did they start? How quickly did they progress?
    • Specific symptoms: Feeding changes, activity level, temperature patterns, respiratory effort, urine output, stool changes, color changes.
    • Any invasive procedures or medical interventions (e.g., central lines, ventilation, surgery).
    • Exposure to sick contacts in the household or NICU.
    • Family history of immunodeficiency.
• Red Flags:
  • Very early onset of symptoms (within hours of birth).
  • Rapid progression of symptoms despite initial interventions.
  • Hypotension or refractory shock.
  • Signs of multi-organ dysfunction (e.g., oliguria, coagulopathy, severe metabolic acidosis).
  • Presence of significant maternal risk factors for EOS (chorioamnionitis, prolonged PROM, untreated GBS).

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC) with Differential:
    • White blood cell (WBC) count: Can be high (>20-25 x 10^9/L) or low (<5 x 10^9/L). Neither is highly sensitive or specific.
    • Absolute neutrophil count (ANC): Neutropenia (<1.5 x 10^9/L for term, <1.0 x 10^9/L for preterm) is highly suggestive of sepsis.
    • Immature-to-total neutrophil ratio (I:T ratio): Immature neutrophils (bands, metamyelocytes, myelocytes) / total neutrophils. An I:T ratio >0.2 is concerning.
    • Thrombocytopenia (<100 x 10^9/L) is common in sepsis/shock.
  • C-Reactive Protein (CRP): Acute phase reactant. Rises within 6-8 hours of inflammation. Values >10 mg/L (or >1.0 mg/dL) are suggestive of infection. Serial CRPs are more informative (e.g., two elevated CRPs 8-24 hours apart).
  • Procalcitonin (PCT): Pro-hormone of calcitonin, elevated in bacterial infections. Rises faster than CRP and can be higher in severe sepsis. Values >2 ng/mL are concerning. Higher values correlate with severity.
  • Blood Culture: The gold standard for diagnosis. Obtain 0.5-1 mL from a peripheral vein for each bottle (aerobic/anaerobic) or a single aerobic bottle. Culture should be obtained before antibiotics are administered.
  • Urine Culture: Via catheterization or suprapubic aspirate. Not routinely done for EOS, but essential for LOS (especially >72 hours of life). Bag urine samples are prone to contamination and should not be used for diagnosis.
  • Cerebrospinal Fluid (CSF) Analysis and Culture: Indicated if there are neurological symptoms, positive blood culture, or suspicion of meningitis (e.g., in EOS with positive blood cultures, or any LOS). Parameters: WBC count (pleocytosis), protein, glucose, Gram stain, culture. Thresholds for pleocytosis vary by age.
  • Serum Lactate: Reflects tissue hypoperfusion. Elevated levels (>2-4 mmol/L) indicate anaerobic metabolism and are a critical marker of shock severity and response to resuscitation.
  • Blood Gas (Arterial or Capillary): To assess acid-base status (metabolic acidosis is common), oxygenation, and ventilation.
  • Blood Glucose: Hypoglycemia or hyperglycemia is common in sepsis.
  • Electrolytes, Renal Function (Creatinine, BUN), Liver Function Tests (ALT, AST, Bilirubin): To assess for organ dysfunction.
  • Coagulation Profile (PT, PTT, Fibrinogen, D-dimer): To assess for coagulopathy and DIC.
• Confirmatory:
  • Positive bacterial or fungal growth in a sterile body fluid culture (blood, CSF, urine).
• Monitoring:
  • Repeat CBC, CRP, Procalcitonin: To monitor response to therapy and guide duration of antibiotics.
  • Serial Lactate and Blood Gas: To monitor response to fluid and vasopressor therapy.
  • Continuous Glucose Monitoring (if unstable).
  • Electrolytes, Renal Function, Liver Function: To monitor for organ dysfunction and guide supportive care.

Imaging

• Recommended:
  • Chest X-ray (CXR): If respiratory symptoms are present (e.g., tachypnea, grunting, desaturations). May show infiltrates, effusions, or signs of acute respiratory distress syndrome (ARDS).
  • Abdominal X-ray (AXR): If abdominal distension, feeding intolerance, or bloody stools are present, to rule out necrotizing enterocolitis (NEC).
  • Head Ultrasound (HUS): If neurological symptoms (e.g., seizures, bulging fontanelle) are present, or in preterm infants with sepsis, to assess for ventriculitis, hydrocephalus, or intraventricular hemorrhage.
• Advanced:
  • Echocardiogram: To assess cardiac function (myocardial contractility, ejection fraction), identify cardiac shunts (e.g., PDA, PFO), and evaluate for persistent pulmonary hypertension of the newborn (PPHN) which can complicate sepsis. Essential in cases of refractory shock to guide inotrope selection.
  • Renal Ultrasound: If oliguria or anuria persists, to rule out structural abnormalities or assess for acute kidney injury.
  • MRI Brain: For detailed assessment of brain injury (e.g., white matter injury, infarcts) if neurological deficits persist after stabilization.

Management

Acute Management of Neonatal Septic Shock is a MEDICAL EMERGENCY requiring immediate, coordinated, and aggressive intervention.

Acute Management

• Immediate (First-Hour Interventions - "Golden Hour"):
  1. Airway, Breathing, Circulation (ABCs):
     • Airway: Ensure patent airway. May require intubation if respiratory distress, apnea, or altered consciousness.
     • Breathing: Provide ventilatory support (Nasal CPAP, mechanical ventilation) to ensure adequate oxygenation and ventilation. Target SpO2 90-95%.
     • Circulation: Establish rapid vascular access (umbilical venous catheter, peripheral IV).
  2. Fluid Resuscitation: Administer rapid intravenous fluid boluses of crystalloids (0.9% Normal Saline or Ringer's Lactate).
     • Initial Bolus: 10-20 mL/kg over 5-10 minutes.
     • Repeat Boluses: Can repeat 1-2 more boluses (total 30-60 mL/kg) if no improvement in perfusion (CRT, heart rate, blood pressure) and no signs of fluid overload (e.g., rales, hepatomegaly). Administer judiciously in preterm infants due to risk of IVH and pulmonary edema.
  3. Empiric Antibiotics: Administer broad-spectrum antibiotics immediately after cultures are obtained, without waiting for results.
     • EOS/LOS: Ampicillin (100 mg/kg/dose IV every 12 hours for term, every 8 hours for preterm) + Gentamicin (4-5 mg/kg/dose IV every 24-48 hours depending on gestational age and renal function).
     • Alternatives: Cefotaxime (50 mg/kg/dose IV every 12 hours for term, every 8 hours for preterm) can replace gentamicin, especially if meningitis is highly suspected or if gentamicin resistance is a concern.
     • Nosocomial LOS/High Risk of MRSA/Fungal: Consider adding Vancomycin (15 mg/kg/dose IV every 8-12 hours) and/or Amphotericin B (0.5-1 mg/kg/dose IV daily) if risk factors are present (e.g., prolonged central line, previous broad-spectrum antibiotics, persistent neutropenia, fungal colonization).
• Stabilization (Early Management Priorities):
  1. Vasopressor/Inotrope Support: If hypotension or poor perfusion persists despite 40-60 mL/kg fluid resuscitation, initiate vasoactive medications.
     • First-line: Dopamine (5-20 mcg/kg/min IV continuous infusion) for inotropic and vasopressor effects.
     • Second-line/Alternative: Norepinephrine (0.05-0.3 mcg/kg/min IV continuous infusion) if primary vasodilatory shock. Epinephrine (0.05-0.3 mcg/kg/min IV continuous infusion) for cardiogenic shock or refractory shock.
     • Dobutamine (5-20 mcg/kg/min IV continuous infusion) if primary myocardial dysfunction with adequate SVR.
     • Vasopressin (0.0002-0.002 units/kg/min) can be considered in refractory vasodilatory shock.
  2. Correction of Metabolic Derangements:
     • Acidosis: Correct severe metabolic acidosis (pH <7.20) with Sodium Bicarbonate (1-2 mEq/kg IV slow push over 30-60 minutes) if ongoing tissue hypoperfusion persists despite adequate volume and vasopressor support.
     • Hypoglycemia: Treat with IV dextrose bolus (2 mL/kg of D10W), then maintain glucose infusion rate (GIR) to keep blood glucose 50-120 mg/dL.
     • Hypocalcemia: Correct if ionized calcium <1.0 mmol/L, especially if myocardial dysfunction.
  3. Temperature Control: Maintain normothermia (36.5-37.5°C) using radiant warmers or incubators. Avoid overheating or chilling.
  4. Blood Product Transfusion:
     • Packed Red Blood Cells (PRBCs): If hemoglobin <10-12 g/dL with ongoing shock, or for severe anemia. Target Hb >12 g/dL in severe shock.
     • Fresh Frozen Plasma (FFP): For coagulopathy (prolonged PT/PTT) with active bleeding or prior to invasive procedures.
     • Platelets: If platelet count <50,000/microL with active bleeding or <20,000-30,000/microL in unstable patients.
• Emergency:
  • If central access is difficult, consider intraosseous (IO) access for fluids and medications.
  • Early recognition of decompensated shock and immediate escalation of care.
  • Consider stress dose hydrocortisone (1-2 mg/kg/day divided q6-12h or 0.1 mg/kg/hr continuous infusion) in infants with refractory shock, especially those on high doses of vasopressors, as adrenal insufficiency can contribute to refractory shock.

Chronic Management

(Less applicable for acute shock, focuses on post-stabilization and recovery) - Pharmacological: * Targeted Antibiotics: De-escalate antibiotics based on culture results and clinical response. Duration usually 7-10 days for uncomplicated bacteremia, 10-14 days for pneumonia, 14-21 days for meningitis, or longer for osteomyelitis/septic arthritis. * Weaning of Vasoactive Agents: Gradually reduce dosages as hemodynamic stability is achieved, guided by clinical signs and blood pressure. * Supportive Medications: Diuretics for fluid overload, sedatives for ventilated infants, anticonvulsants if seizures persist. - Non-pharmacological: * Nutritional Support: Early enteral feeding is encouraged once hemodynamically stable, if GI function allows. Otherwise, maintain TPN. * Developmental Care: Provide a calm, quiet environment. Minimize noxious stimuli. Encourage kangaroo care once stable. * Physical Therapy/Occupational Therapy: Initiate early for neurodevelopmental support, especially after prolonged illness. - Monitoring: * Neurodevelopmental Follow-up: High risk of long-term impairment. Regular follow-up with a developmental pediatrician, audiologist (hearing screen), and ophthalmologist (retinopathy of prematurity screening) is crucial. * Growth Monitoring: Regular weight, length, head circumference. * Organ System Function: Monitor for long-term complications related to kidney, lung, or cardiac injury.

Treatment Algorithms

• First-Line (Initial Response):
  1. Recognize Shock: Clinical signs of poor perfusion, hypotension.
  2. ABCs: Secure airway, provide oxygen/ventilation. Establish rapid IV access.
  3. Fluid Bolus: 10-20 mL/kg 0.9% NS over 5-10 minutes.
  4. Cultures: Blood culture, CSF, urine (if appropriate).
  5. Empiric Antibiotics: Ampicillin + Gentamicin/Cefotaxime.
  6. Reassess Perfusion: If no improvement, repeat fluid bolus (up to 40-60 mL/kg total).
  7. Initiate Vasopressors: If still hypotensive/poorly perfused: Dopamine (5-20 mcg/kg/min).
• Second-Line (If First-Line Inadequate):
  1. Optimize Ventilation: Ensure adequate oxygenation and ventilation (consider HFOV for severe ARDS).
  2. Add/Change Vasopressor: If dopamine ineffective, add Norepinephrine (0.05-0.3 mcg/kg/min) for distributive shock, or Epinephrine (0.05-0.3 mcg/kg/min) for cardiogenic component. Consider Dobutamine if primary myocardial dysfunction.
  3. Consider Stress-Dose Hydrocortisone: If refractory shock despite high-dose vasopressors (1-2 mg/kg/day divided or continuous).
  4. Correct Severe Metabolic Derangements: Treat profound acidosis, hypoglycemia, hypocalcemia.
  5. Targeted Antibiotics: Based on culture sensitivities. Consider adding Vancomycin or antifungals if risk factors for resistant organisms/fungi.
• Refractory Cases:
  • Extracorporeal Membrane Oxygenation (ECMO): Considered in highly selected cases of severe cardiorespiratory failure refractory to conventional management, provided the infant meets strict criteria (e.g., reversible lung disease, no severe IVH).
  • Inhaled Nitric Oxide (iNO): If persistent pulmonary hypertension of the newborn (PPHN) is significant and contributing to hypoxemia.
  • Therapeutic Hypothermia: Not indicated for septic shock, only for hypoxic-ischemic encephalopathy.

Complications

• Common:
  • Acute Respiratory Failure / ARDS (Acute Respiratory Distress Syndrome)
  • Acute Kidney Injury (AKI)
  • Disseminated Intravascular Coagulation (DIC)
  • Necrotizing Enterocolitis (NEC)
  • Metabolic Acidosis
  • Hypoglycemia / Hyperglycemia
  • Seizures
• Serious:
  • Multi-Organ Dysfunction Syndrome (MODS)
  • Persistent Pulmonary Hypertension of the Newborn (PPHN)
  • Intraventricular Hemorrhage (IVH) in preterm infants (related to fluid shifts and blood pressure instability)
  • Periventricular Leukomalacia (PVL)
  • Brain abscess or ventriculitis (if meningitis)
  • Death
• Long-term:
  • Neurodevelopmental Impairment: Cerebral palsy, cognitive delays, learning disabilities, behavioral problems.
  • Hearing Loss: Especially with aminoglycoside use, but also a direct complication of sepsis.
  • Vision Impairment.
  • Chronic Lung Disease (Bronchopulmonary Dysplasia - BPD).
  • Chronic Kidney Disease.
  • Increased susceptibility to future infections.
  • Growth failure.

Prognosis

• Factors:
  • Gestational Age and Birth Weight: Prematurity and low birth weight are major risk factors for worse outcomes.
  • Severity of Shock: Presence of hypotension, need for high-dose vasopressors, and number of failing organs (MODS) correlate with higher mortality and morbidity.
  • Pathogen: Virulence of the infecting organism (e.g., some Gram-negative bacilli, fungi) can impact outcome.
  • Response to Therapy: Prompt and effective treatment of shock improves prognosis.
  • Presence of Complications: Development of severe complications like IVH, NEC, or severe ARDS worsens prognosis.
• Survival: Mortality rates vary widely. In developed countries, overall mortality for neonatal sepsis is around 5-10%, but for septic shock, it can be as high as 20-50%, especially in very low birth weight infants.
• Quality of Life: Survivors of neonatal septic shock are at significantly increased risk for long-term neurodevelopmental impairment (20-50%), requiring ongoing support and therapy.

Prevention

• Primary: Preventing initial occurrence of sepsis.
  • Maternal Screening and Prophylaxis: Routine GBS screening and intrapartum antibiotic prophylaxis for positive mothers or those with risk factors (PROM, fever).
  • Infection Control in NICU: Strict adherence to hand hygiene protocols, aseptic technique for all procedures, skin care protocols.
  • Judicious Use of Invasive Devices: Minimize use of central venous catheters, endotracheal tubes, and urinary catheters. Remove devices as soon as clinically indicated.
  • Early Enteral Feeding and Breastfeeding: Promote breastfeeding and early trophic feeds to establish a healthy gut microbiome and enhance immune function.
  • Probiotic Use: Emerging evidence on select probiotics in high-risk preterm infants for NEC prevention may also reduce late-onset sepsis, but not yet standard of care.
• Secondary: Early detection and intervention to prevent progression to shock.
  • High Index of Suspicion: Maintain a high suspicion for sepsis in any neonate presenting with subtle or non-specific signs of illness.
  • Prompt Evaluation and Workup: Rapid initiation of sepsis workup (cultures, labs) and empiric antibiotics upon suspicion.
  • Early Recognition of Shock: Continuous monitoring of vital signs and perfusion parameters, especially in at-risk infants.
• Tertiary: Preventing complications and minimizing long-term sequelae.
  • Aggressive Management of Shock: Rapid and effective resuscitation to minimize tissue hypoperfusion and organ damage.
  • Optimal Organ Support: Respiratory, circulatory, renal support to prevent MODS.
  • Neuroprotection: Careful fluid management, blood pressure control, and glucose management to minimize brain injury.
  • Rehabilitative Therapies: Early intervention with physical, occupational, and speech therapy for infants at risk of neurodevelopmental impairment.

Special Populations

• Pediatric: N/A (Neonatal is a specific pediatric age group).
• Geriatric: N/A.
• Pregnancy: N/A.
• Comorbidities:
  • Preterm Infants: Higher risk of sepsis, more vulnerable to fluid overload and IVH, less robust hemodynamic response, lower blood pressure thresholds. Requires more cautious fluid administration and lower thresholds for vasopressor initiation.
  • Congenital Heart Disease (CHD): Baseline hemodynamic abnormalities make managing shock complex. Requires careful balancing of systemic and pulmonary circulations. Often require early consultation with cardiology.
  • Congenital Anomalies (e.g., Gastroschisis, Myelomeningocele): Increased risk of infection due to exposed organs or surgical sites.
  • Immunodeficiencies (Primary or Secondary): Susceptible to opportunistic infections; may require aggressive antimicrobial regimens, IVIG, or stem cell transplant.
  • Infants with Perinatal Asphyxia/HIE: Already compromised organs, increased risk of MODS. Fluid and vasopressor management must be balanced with brain perfusion.

Clinical Pearls

• Diagnostic:
  • "Sick-Looking Baby" Rule: Any neonate who "doesn't look right" or has subtle signs of illness (e.g., poor feeding, lethargy, subtle temperature instability) should be considered for a sepsis workup, especially in the first few days of life or with risk factors.
  • Temperature Instability: Hypothermia is often a more ominous sign than fever in neonates with sepsis/shock.
  • Hypotension is Late: By the time hypotension is evident in neonatal septic shock, the infant is often in decompensated shock. Rely on other perfusion indicators like CRT, mottling, and lactate.
  • Serial Markers: A single CRP or PCT level is less informative than serial measurements showing a rising trend or failure to decline with treatment.
  • Blood Culture Volume: Always strive for adequate blood culture volume (0.5-1 mL per bottle) to maximize sensitivity. Even small volumes are better than none.
• Treatment:
  • Time is Tissue: Do not delay empiric antibiotics and initial fluid resuscitation while awaiting lab results or transfer to higher level of care. Every minute counts.
  • Fluid First, Then Pressors: Adequate fluid resuscitation is the cornerstone of initial management. Vasopressors should generally be initiated after 20-40 mL/kg of fluid unless there are clear signs of fluid overload or severe cardiac dysfunction.
  • Consider Adrenal Insufficiency: In refractory shock, especially on high-dose vasopressors, empirical stress-dose hydrocortisone should be considered early.
  • Glucose Management: Hypoglycemia is common and dangerous in sepsis. Monitor blood glucose closely.
• Pitfalls:
  • Underestimation of Severity: Dismissing subtle signs, leading to delayed diagnosis and treatment.
  • Insufficient Fluid Resuscitation: Hesitation to give adequate fluid boluses due to fear of fluid overload, potentially worsening shock.
  • Delaying Antibiotics: Waiting for "definitive" lab results (e.g., positive culture) before initiating empiric antibiotics.
  • Inadequate Monitoring: Failure to continuously monitor perfusion, blood pressure, and organ function.
  • Attributing Symptoms to Other Causes: Misdiagnosing sepsis as purely respiratory distress, hypoglycemia, or other non-infectious causes.

Recent Updates

• Guidelines: The Surviving Sepsis Campaign (SSC) guidelines have recently been updated to include specific recommendations for pediatric septic shock, with a growing focus on neonatal-specific considerations, emphasizing early recognition, fluid resuscitation, and timely antibiotics. The focus remains on goal-directed therapy within the first hour.
• Evidence:
  • Role of Procalcitonin: Increasing evidence supports procalcitonin as a useful biomarker for early diagnosis, risk stratification, and guiding antibiotic discontinuation in neonatal sepsis, though its role in acute shock management is primarily for monitoring response.
  • Optimal Fluid Resuscitation: Ongoing debate regarding the optimal volume and rate of fluid administration in neonatal septic shock, particularly in very preterm infants, to balance adequate perfusion with the risk of fluid overload (e.g., IVH, pulmonary edema). Current recommendations lean towards careful, individualized fluid boluses with frequent reassessment.
  • Vasopressor Choices: Growing evidence on the efficacy and side effect profiles of different vasopressors (dopamine, norepinephrine, epinephrine, dobutamine) in neonates, with increasing recognition of norepinephrine's role in vasodilatory shock.
• Controversies:
  • Routine Use of Corticosteroids: While recommended for refractory shock, the optimal dose, duration, and specific indications for corticosteroids in neonatal septic shock remain an area of active research and debate.
  • Volume of Fluid Boluses: The precise maximum fluid bolus volume before initiating vasopressors is debated, especially in extremely preterm infants.
  • Lactate Clearance as a Goal: While lactate is a crucial marker of perfusion, the clinical utility of targeting specific lactate clearance rates in neonates as a primary resuscitation endpoint is still being refined.

Key References

• Guidelines:
  • Rhodes, A., et al. (2017). Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Critical Care Medicine, 45(3), 486-552. (While not exclusively neonatal, foundational principles apply and newer pediatric-specific guidelines derive from it).
  • Goldstein, B., et al. (2005). International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine, 6(1), 2-8.
  • Polin, R. A., & Committee on Fetus and Newborn. (2012). Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics, 129(5), 1006-1015. (AAP Guideline).
  • Shane, A. L., et al. (2017). Neonatal Sepsis. New England Journal of Medicine, 377(3), 223-233. (Comprehensive review).
• Studies:
  • Recent studies on procalcitonin use in neonates (e.g., meta-analyses on its diagnostic accuracy and role in guiding antibiotic duration).
  • Trials evaluating different fluid resuscitation strategies in pediatric and neonatal shock.
  • Studies on specific vasopressors in neonatal populations.
• Reviews:
  • Wynn, J. L. (2016). Neonatal Sepsis: The Journey from Systemic Inflammatory Response Syndrome to Multisystem Organ Dysfunction. Clinics in Perinatology, 43(4), 585-601.
  • Ng, P. C. (2017). Advances in the diagnosis and management of neonatal sepsis. Archives of Disease in Childhood - Fetal and Neonatal Edition, 102(3), F275-F280.